Cisplatin Supplier-Buyer Network — Trade Flow Analysis

Name: Cisplatin Supplier-Buyer Trade Network Dataset — 233+ Indian Exporters, 20+ Importers, 130+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cisplatin supplier network, Cisplatin buyers, pharmaceutical export India, Cisplatin trade data

TransData Nexus

Cisplatin

India Pharmaceutical Trade Intelligence

$12.8M233 Suppliers130 CountriesHS 30049047

ExportsIndia → TAIWAN12.4%India → HUNGARY10.7%

ImportsGERMANY → India$9.5K UNITED STATES → India$2.3K

#1 Supplier: FRESENIUS KABI

Who Supplies Cisplatin? Top Manufacturers & Buyers 2026 — FRESENIUS KABI ONCOLOGY LIMITED Leads | TransData Nexus | TransData Nexus

1FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Cisplatin exporter from India, with a market share of 11.4% and a total export value of $1.5M across 60 shipments. Their average shipment value of $24.4K is above the market average of $7.6K, suggesting premium or bulk contract pricing.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FRESENIUS KABI TAIWAN LTD — $439.1K across 18 shipments (30.0% of this supplier's total exports)

• FRESENIUS KABI TAIWAN LTD — $275.8K across 11 shipments (18.9% of this supplier's total exports)

• FRESENIUS KABI TAIWAN LTD — $271.0K across 11 shipments (18.5% of this supplier's total exports)

• FRESENIUS KABI TAIWAN LTD — $262.1K across 11 shipments (17.9% of this supplier's total exports)

• FRESENIUS KABI (THAILAND) LTD — $214.0K across 9 shipments (14.6% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED's per-shipment value of $24.4K is 223% above the market average of $7.6K, consistent with large-order contracts or value-added formulations.

2NV REMEDIES PRIVATE LIMITED

NV REMEDIES PRIVATE LIMITED is the second-largest Cisplatin exporter from India, with a market share of 10.1% and a total export value of $1.3M across 4 shipments. Their average shipment value of $325.3K is above the market average of $7.6K, suggesting premium or bulk contract pricing.

NV REMEDIES PRIVATE LIMITED serves 1 named buyer in our database. UKRPHARMGROUP LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• UKRPHARMGROUP LLC — $1.3M across 4 shipments (100.0% of this supplier's total exports)

Key Insight: NV REMEDIES PRIVATE LIMITED's per-shipment value of $325.3K is 4207% above the market average of $7.6K, consistent with large-order contracts or value-added formulations.

3INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the third-largest Cisplatin exporter from India, with a market share of 6.1% and a total export value of $786.9K across 73 shipments. Their average shipment value of $10.8K is above the market average of $7.6K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• XXCORXXHEAXXHCAXX INXX — $336.3K across 31 shipments (42.7% of this supplier's total exports)

• XXCORXXHEAXXHCAXX PTXXLIMITED — $159.6K across 15 shipments (20.3% of this supplier's total exports)

• ACCORD HEALTHCARE INC — $133.7K across 12 shipments (17.0% of this supplier's total exports)

• ACCORD HEALTHCARE PT — $79.4K across 7 shipments (10.1% of this supplier's total exports)

• XXCORXXNL XX XXB — $78.0K across 7 shipments (9.9% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $10.8K is 43% above the market average of $7.6K, consistent with large-order contracts or value-added formulations.

4VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the fourth-largest Cisplatin exporter from India, with a market share of 5.1% and a total export value of $653.5K across 121 shipments. Their average shipment value of $5.4K is below the market average of $7.6K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• H B C L — $231.8K across 43 shipments (35.5% of this supplier's total exports)

• ALPHARMA S A S — $114.1K across 21 shipments (17.5% of this supplier's total exports)

• P P — $108.0K across 20 shipments (16.5% of this supplier's total exports)

• A.S.A.S — $106.7K across 20 shipments (16.3% of this supplier's total exports)

• U T SA DE CV — $93.0K across 17 shipments (14.2% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (121 shipments) at a per-shipment value of $5.4K, indicating a broad distribution network with many smaller, regular orders.

5MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Cisplatin exporter from India, with a market share of 4.8% and a total export value of $617.8K across 18 shipments. Their average shipment value of $34.3K is above the market average of $7.6K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. CSP MYLAN IRELAND LTD is the dominant customer, accounting for 52.9% of this supplier's tracked business. Top customers include:

• CSP MYLAN IRELAND LTD — $326.7K across 10 shipments (52.9% of this supplier's total exports)

• CSP VIATRIS SANTE AT — $124.4K across 4 shipments (20.1% of this supplier's total exports)

• CSP P O VIATRIS SANT — $81.3K across 2 shipments (13.2% of this supplier's total exports)

• CSP MYLAN IRELAND LI — $45.8K across 1 shipments (7.4% of this supplier's total exports)

• CSP — $39.6K across 1 shipments (6.4% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $34.3K is 354% above the market average of $7.6K, consistent with large-order contracts or value-added formulations.

6GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the fifth-largest Cisplatin exporter from India, with a market share of 4.1% and a total export value of $530.1K across 11 shipments. Their average shipment value of $48.2K is above the market average of $7.6K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 2 named buyers in our database. SCIEGEN PHARMACEUTICALS INC is the dominant customer, accounting for 62.2% of this supplier's tracked business. Top customers include:

• SCIEGEN PHARMACEUTICALS INC — $329.4K across 7 shipments (62.2% of this supplier's total exports)

• FOSUN PHARMA USA INC — $200.6K across 4 shipments (37.8% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $48.2K is 538% above the market average of $7.6K, consistent with large-order contracts or value-added formulations.

1Taiwan

Taiwan ranks as the first-largest destination for Cisplatin imports from India, with a total trade value of $1.6M across 20 shipments — representing a 12.4% share of all Cisplatin exports. The average shipment value of $79.6K is above the global average of $7.6K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Cisplatin importers in Taiwan: FRESENIUS KABI TAIWAN LTD. is the largest buyer, accounting for 42.8% ($680.8K) of this market's total imports.

• FRESENIUS KABI TAIWAN LTD. — $680.8K (42.8% of Taiwan's total)

• FRESENIUS KABI TAIWAN LTD., — $347.3K (21.8% of Taiwan's total)

• FRESENIUS KABI TAIWAN LIMITED — $287.6K (18.1% of Taiwan's total)

Key Insight: Taiwan's per-shipment average of $79.6K (953% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Taiwan is a key market for Cisplatin imports from India.

Primary Market

Secondary Market

2Hungary

Hungary ranks as the second-largest destination for Cisplatin imports from India, with a total trade value of $1.4M across 4 shipments — representing a 10.7% share of all Cisplatin exports. The average shipment value of $343.7K is above the global average of $7.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cisplatin importers in Hungary: UKRPHARMGROUP LLC is the largest buyer, accounting for 94.7% ($1.3M) of this market's total imports.

• UKRPHARMGROUP LLC — $1.3M (94.7% of Hungary's total)

Key Insight: Hungary's per-shipment average of $343.7K (4449% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Hungary is a key market for Cisplatin imports from India.

Primary Market

Secondary Market

3France

France ranks as the third-largest destination for Cisplatin imports from India, with a total trade value of $922.2K across 10 shipments — representing a 7.2% share of all Cisplatin exports. The average shipment value of $92.2K is above the global average of $7.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cisplatin importers in France: CSP MYLAN IRELAND LTD is the largest buyer, accounting for 49.6% ($457.6K) of this market's total imports.

• CSP MYLAN IRELAND LTD — $457.6K (49.6% of France's total)

Key Insight: France's per-shipment average of $92.2K (1121% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Cisplatin imports from India.

Primary Market

Secondary Market

4United States

United States ranks as the fourth-largest destination for Cisplatin imports from India, with a total trade value of $891.1K across 11 shipments — representing a 6.9% share of all Cisplatin exports. The average shipment value of $81.0K is above the global average of $7.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Cisplatin importers in United States: SCIEGEN PHARMACEUTICALS INC is the largest buyer, accounting for 37.0% ($329.4K) of this market's total imports.

• SCIEGEN PHARMACEUTICALS INC — $329.4K (37.0% of United States's total)

• FOSUN PHARMA USA INC — $200.6K (22.5% of United States's total)

Key Insight: United States's per-shipment average of $81.0K (972% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Cisplatin imports from India.

Primary Market

Secondary Market

5Thailand

Thailand ranks as the fifth-largest destination for Cisplatin imports from India, with a total trade value of $876.5K across 6 shipments — representing a 6.8% share of all Cisplatin exports. The average shipment value of $146.1K is above the global average of $7.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cisplatin importers in Thailand: FRESENIUS KABI (THAILAND) LTD is the largest buyer, accounting for 35.4% ($310.5K) of this market's total imports.

• FRESENIUS KABI (THAILAND) LTD — $310.5K (35.4% of Thailand's total)

Key Insight: Thailand's per-shipment average of $146.1K (1834% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Cisplatin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cisplatin.
2.Flow Mapping: 233 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,701 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 130 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,701 Verified Shipments

233 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cisplatin

Cisplatin

Who Supplies Cisplatin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cisplatin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cisplatin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1FRESENIUS KABI ONCOLOGY LIMITED

2NV REMEDIES PRIVATE LIMITED

3INTAS PHARMACEUTICALS LIMITED

4VENUS REMEDIES LIMITED

5MYLAN LABORATORIES LIMITED

6GLAND PHARMA LIMITED

From Indian Factories to Global Pharmacies — How Cisplatin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cisplatin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Taiwan

2Hungary

3France

4United States

5Thailand

People Also Ask — Cisplatin Supplier & Trade Network

Cisplatin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology